Streetbeat News

Stock Prices

GYRE

Gyre Therapeutics has announced the publication of a manuscript in the Journal of Gastroenterology and Hepatology. The manuscript highlights the potential of Hydronidone (F351) as a therapy for liver fibrosis through the apoptotic pathway in hepatic stellate cells.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:06 pm

BTCUSD

SMH

SPY

Retail sales have declined, while chip stocks continue to rise. Bitcoin has fallen below $65,000.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:03 pm

ZS

Investors with significant capital have shown a bullish stance on Zscaler (NASDAQ:ZS), with 17 call options and 1 put option spotted by Benzinga's options scanner. The trading activity suggests a price range of $140 to $200 for Zscaler over the next three months. Analysts have mixed ratings, with a consensus target price of $251.6.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 8:01 pm

BSX

21 analysts have provided ratings on Boston Scientific (NYSE:BSX) over the last three months, with a majority being bullish. The average 12-month price target is $82.81, reflecting a 10.93% increase from the previous target. Analysts have raised their ratings and price targets, indicating positive sentiment towards the company.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 8:00 pm

TOL

Toll Brothers (NYSE:TOL) has significantly outperformed the market over the past 5 years, delivering an average annual return of 26.43%. A $1000 investment in TOL 5 years ago would now be worth $3,233.61. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 8:00 pm

ZTS

Zoetis (NYSE:ZTS) has outperformed the market over the past 10 years with an average annual return of 18.04%, surpassing the market by 7.14% annually. A $100 investment in ZTS 10 years ago would be worth $520.85 today. The article highlights the impact of compounded returns on long-term investments.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 8:00 pm

NXL

Nexalin Technology shares are trading higher after the company was awarded a US patent on 'Transcranial alternating current dynamic frequency stimulation (TACS) method for Alzheimer's and Dementia.'

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 7:56 pm

NVDA

Nvidia Corp (NASDAQ:NVDA) shares hit new all-time highs following positive analyst coverage. Rosenblatt analyst Hans Mosesmann raised the price target to $200, citing strong earnings potential from Nvidia’s hardware and software. Wells Fargo also raised its price target to $155.

Portfolio Pulse from Adam Eckert

June 18, 2024 | 7:54 pm

LEN

TOL

Toll Brothers shares are trading lower after the DOJ filed a lawsuit against the company. Housing stocks, including Lennar, have been down today in sympathy.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 7:48 pm

CEG

Constellation Energy (NYSE:CEG) has seen a 65.96% increase in its short percent of float, now at 2.34% of all regular shares. This indicates a rise in bearish sentiment among investors. However, its short interest is still below the peer group average of 2.37%.

Portfolio Pulse from Benzinga Insights

June 18, 2024 | 7:45 pm